Patents by Inventor Eric Delmar

Eric Delmar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION AND METHOD
    Publication number: 20090155903
    Abstract: The invention provides compounds, pharmaceutical compositions and methods for the therapeutic treatment and prevention of neurodegenerative disorder and other A?42-related diseases and disorders.
    Type: Application
    Filed: March 21, 2005
    Publication date: June 18, 2009
    Applicant: Myriad Genetics, Incorporated
    Inventors: Rachel M. Slade, Warren S. Weiner, Eric Delmar, Yevgeniya Klimova, Richard Trovato
  • Compounds, compositions, and methods employing same
    Patent number: 7547804
    Abstract: Compounds and pharmaceutical compositions containing the same are provided, which are useful in therapeutic treatment or prevention of various diseases.
    Type: Grant
    Filed: January 18, 2005
    Date of Patent: June 16, 2009
    Assignee: Myriad Genetics, Inc.
    Inventors: Ashok C. Bajji, Esther Arranz, Jayasree M. Srinivasan, Eric Delmar, Rachel Slade, Jon Adam Willardsen
  • Calcium receptor-active molecules
    Publication number: 20060229470
    Abstract: The present invention relates to the different roles inorganic ion receptors have in cellular and body processes. The present invention features: (1) molecules which can modulate one or more inorganic ion receptor activities, preferably the molecule can mimic or block an effect of an extracellular ion on a cell having an inorganic ion receptor, more preferably the extracellular ion is Ca2+ and the effect is on a cell having a calcium receptor; (2) inorganic ion receptor proteins and fragments thereof, preferably calcium receptor proteins and fragments thereof; (3) nucleic acids encoding inorganic ion receptor proteins and fragments thereof, preferably calcium receptor proteins and fragments thereof; (4) antibodies and fragments thereof, targeted to inorganic ion receptor proteins, preferably calcium receptor protein; and (5) uses of such molecules, proteins, nucleic acids and antibodies.
    Type: Application
    Filed: October 4, 2005
    Publication date: October 12, 2006
    Applicant: NPS Pharmaceuticals, Inc.
    Inventors: Bradford Van Wagenen, Manuel Balandrin, Eric DelMar, Edward Nemeth
  • Compounds, compositions, and methods employing same
    Publication number: 20050187300
    Abstract: Compounds and pharmaceutical compositions containing the same are provided, which are useful in therapeutic treatment or prevention of various diseases.
    Type: Application
    Filed: January 18, 2005
    Publication date: August 25, 2005
    Applicant: Myriad Genetics, Incorporated
    Inventors: Ashok Bajji, Esther Arranz, Jayasree Srinlvasan, Eric Delmar, Rachel Slade, Jon Willardsen
  • Insecticidally effective peptides isolatable from phidippus spider venom
    Patent number: 5756459
    Abstract: This invention provides a family of insecticidally effective proteins and particular members of that family which may be isolated from the venom of the spider Phidippus audax, DNA encoding such proteins, insecticidal compositions of these proteins or the DNA encoding them, and methods for controlling invertebrate pests. Recombinant expression vectors and host cells and methods for producing insecticidally effective peptides are also provided.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 26, 1998
    Assignees: FMC Corporation, NPS Pharmaceuticals, Inc.
    Inventors: John Randolph Hunter Jackson, Eric DelMar, Janice Helen Johnson, Robert Marden Kral, Jr.